These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3355846)

  • 1. Probucol reduces the rate of association of apolipoprotein C-III with dimyristoylphosphatidylcholine.
    McLean LR; Hagaman KA
    Biochim Biophys Acta; 1988 Apr; 959(3):201-5. PubMed ID: 3355846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of probucol administration on lipoprotein cholesterol and apolipoproteins in normolipemic males.
    Berg A; Frey I; Baumstark M; Keul J
    Atherosclerosis; 1988 Jul; 72(1):49-54. PubMed ID: 3214458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant activity of probucol and its effects on phase transitions in phosphatidylcholine liposomes.
    McLean LR; Hagaman KA
    Biochim Biophys Acta; 1990 Nov; 1029(1):161-6. PubMed ID: 2223806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the serum amyloid A proteins with phospholipid.
    Bausserman LL; Herbert PN; Forte T; Klausner RD; McAdam KP; Osborne JC; Rosseneu M
    J Biol Chem; 1983 Sep; 258(17):10681-8. PubMed ID: 6411718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of free apolipoprotein-mediated cellular lipid efflux by probucol.
    Tsujita M; Yokoyama S
    Biochemistry; 1996 Oct; 35(40):13011-20. PubMed ID: 8855936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of probucol on plasma lipids, lipoproteins and parameters of high density lipoprotein metabolism.
    Wetterau JR; Combs KA; Albers HW; Lamkin G; Stein EA; Barnhart RL; Chi EM; Jackson RL; Harmony JA
    Horm Metab Res; 1992 Jun; 24(6):289-96. PubMed ID: 1634195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution of lipoproteins. II. Lipid-protein interaction between dimyristoyl-lecithin and dimyristoyl-lecithin:cholesterol vesicles and purified apolipoprotein C-I and C-III2 studied by isomeric spin-labelled lecithins.
    Vaughan DJ; Breckenridge WC; Stanacev NZ
    Can J Biochem; 1980 Jul; 58(7):592-8. PubMed ID: 6256038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of cholesterol into apolipoprotein A-I-dimyristoylphosphatidylcholine recombinants.
    Lundberg BB
    Biochim Biophys Acta; 1988 Sep; 962(2):265-74. PubMed ID: 3139042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of tryptic peptides of apolipoprotein B-100 with dimyristoylphosphatidylcholine.
    Cardin AD; Jackson RL
    Biochim Biophys Acta; 1986 Jul; 877(3):366-71. PubMed ID: 3730406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein lipase-catalyzed hydrolysis of dimyristoylphosphatidylcholine. Effect of lipid organization and apolipoprotein C-II on enzyme activity.
    Shinomiya M; Jackson RL
    Biochim Biophys Acta; 1984 Jul; 794(2):177-82. PubMed ID: 6733134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermodynamics of lipid--protein associations: the enthalpy of binding of Apo C-III to synthetic phosphatidylcholines.
    Pownall HJ; Massey JB; Hsu FJ; Gotto AM
    Can J Biochem; 1981 Aug; 59(8):700-8. PubMed ID: 6895345
    [No Abstract]   [Full Text] [Related]  

  • 12. Dynamics of lipid-protein interactions. Interaction of apolipoprotein A-II from human plasma high density lipoproteins with dimyristoylphosphatidylcholine.
    Massey JB; Gotto AM; Pownall HJ
    J Biol Chem; 1980 Nov; 255(21):10167-73. PubMed ID: 6776110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probucol prevents lipid storage in macrophages.
    Yamamoto A; Takaichi S; Hara H; Nishikawa O; Yokoyama S; Yamamura T; Yamaguchi T
    Atherosclerosis; 1986 Dec; 62(3):209-17. PubMed ID: 3801087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of probucol on lipoprotein protein kinetics.
    Nestel PJ
    Artery; 1982; 10(2):95-8. PubMed ID: 7092582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probucol: pharmacology and clinical application.
    Zimetbaum P; Eder H; Frishman W
    J Clin Pharmacol; 1990 Jan; 30(1):3-9. PubMed ID: 2406299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemia.
    LeLorier J; DuBreuil-Quidoz S; Lussier-Cacan S; Huang YS; Davignon J
    Arch Intern Med; 1977 Oct; 137(10):1429-34. PubMed ID: 335998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamics of lipid-protein association. Enthalphy of association of apolipoprotein A-II with dimyristoylphosphatidylcholine-cholesterol mixtures.
    Massey JB; Gotto AM; Pownall HJ
    Biochim Biophys Acta; 1984 Jun; 794(1):137-41. PubMed ID: 6428456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of apolipoprotein A-I with dimyristoylphosphatidylcholine particles of various sizes.
    Jonas A; Drengler SM; Kaplan JS
    J Biol Chem; 1981 Mar; 256(5):2420-6. PubMed ID: 6780564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Probucol: mechanism of action (author's transl)].
    Infante R
    Nouv Presse Med; 1980 Oct; 9(40):2976-80. PubMed ID: 7443434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of plasma apolipoproteins with lipid monolayers.
    Jackson RL; Pattus F; Demel RA
    Biochim Biophys Acta; 1979 Oct; 556(3):369-87. PubMed ID: 226140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.